Publicaciones en las que colabora con Ruth Rama Dellepiane (25)

2020

  1. Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents

    AAPS PharmSciTech, Vol. 21, Núm. 5

2019

  1. Double origin of the extensor hallucis longus muscle: a case report

    Surgical and Radiologic Anatomy, Vol. 41, Núm. 12, pp. 1421-1423

  2. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview

    Cancer Biology and Medicine, Vol. 16, Núm. 4, pp. 688-699

2018

  1. DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer

    European Journal of Anatomy, Vol. 22, Núm. 4, pp. 303-316

2016

  1. Last advances in nanocarriers-based drug delivery systems for colorectal cancer

    Current Drug Delivery, Vol. 13, Núm. 6, pp. 830-838

2015

  1. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444

  2. Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells

    PLoS ONE, Vol. 10, Núm. 7

  3. Specific colon cancer cell cytotoxicity induced by bacteriophage E gene expression under transcriptional control of carcinoembryonic antigen promoter

    International Journal of Molecular Sciences, Vol. 16, Núm. 6, pp. 12601-12615

  4. Tissue Specific Promoters in Colorectal Cancer

    Disease Markers, Vol. 2015

2014

  1. Cancer stem cells and their implication in breast cancer

    European Journal of Clinical Investigation, Vol. 44, Núm. 7, pp. 678-687

2013

  1. Antitumor properties of natural compounds and related molecules

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 203-215

  2. Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance

    Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541

2012

  1. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells

    Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567

  2. How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment

    Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888

2011

  1. E phage gene transfection associated to chemotherapeutic agents increases apoptosis in lung and colon cancer cells

    Bioengineered Bugs, Vol. 2, Núm. 3, pp. 163-167

  2. Multidrug resistance and rhabdomyosarcoma (review)

    Oncology Reports, Vol. 26, Núm. 4, pp. 755-761

  3. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells

    Biomedicine and Pharmacotherapy, Vol. 65, Núm. 4, pp. 260-270

2010

  1. E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents

    International Journal of Oncology, Vol. 37, Núm. 6, pp. 1503-1514

  2. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells

    Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 1, pp. 69-78

  3. Promotion of human adipose-derived stem cell proliferation mediated by exogenous nucleosides

    Cell Biology International, Vol. 34, Núm. 9, pp. 917-924